John D. Quisel, SVP, Corporate Development, GC & Secretary at ACCELERON PHARMA INC (XLRN), sold 1,204 shares at $39.16 ($46K) on 2018-04-03, disclosed to the SEC on 2018-04-04.
Scheduled sale ($46k) by SVP, Corporate Development, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.33 | 1,104 | $42K | 91.5% |
| 2 | $39.16 | 100 | $4K | 8.5% |
| Total | $38.40 avg | 1,204 | $46K | 100% |
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |